Azithromycin 1.5% Ophthalmic SolutionIn Purulent Bacterial or Trachomatous Conjunctivitis

被引：0
|
作者：
Karly P. Garnock-Jones
机构：
[1] Adis,
来源：
Drugs | 2012年 / 72卷
关键词：
Azithromycin; Tobramycin; Conjunctivitis; Ophthalmic Solution; Clinical Cure Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The second-generation macrolide azithromycin is available as a 1.5% ophthalmic solution for use in the treatment of bacterial or trachomatous conjunctivitis. This article reviews the pharmacological properties of azithromycin 1.5% ophthalmic solution and its clinical efficacy and tolerability in patients with purulent bacterial conjunctivitis or trachomatous conjunctivitis caused by Chlamydia trachomatis.
引用
收藏
页码：361 / 373
页数：12
相关论文
共 50 条
  • [1] Azithromycin 1.5% Ophthalmic Solution In Purulent Bacterial or Trachomatous Conjunctivitis
    Garnock-Jones, Karly P.
    DRUGS, 2012, 72 (03) : 361 - 373
  • [2] Azithromycin 1.5 % ophthalmic solution: A guide to its use in purulent bacterial conjunctivitis and trachomatous conjunctivitis
    Keating G.M.
    Lyseng-Williamson K.A.
    Garnock-Jones K.P.
    Drugs & Therapy Perspectives, 2013, 29 (4) : 97 - 101
  • [3] Moxifloxacin 0.5% Ophthalmic SolutionIn Bacterial Conjunctivitis
    Gillian M. Keating
    Drugs, 2011, 71 : 89 - 99
  • [4] Efficacy and Safety of Azithromycin 1.5% Eye Drops for Purulent Bacterial Conjunctivitis in Pediatric Patients
    Bremond-Gignac, Dominique
    Mariani-Kurkdjian, Patricia
    Beresniak, Ariel
    El Fekih, Lamia
    Bhagat, Yasmin
    Pouliquen, Pascale
    Delval, Laurent
    Goldschmidt, Pablo
    Bingen, Edouard
    Cochereau, Isabelle
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (03) : 222 - 226
  • [5] Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis
    Bremond-Gignac, Dominique
    Nezzar, Hachemi
    Bianchi, Paolo Emilio
    Messaoud, Riadh
    Lazreg, Sihem
    Voinea, Liliana
    Speeg-Schatz, Claude
    Hartani, Dahbia
    Kaercher, Thomas
    Kocyla-Karczmarewicz, Beata
    Murta, Joaquim
    Delval, Laurent
    Renault, Didier
    Chiambaretta, Frederic
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (06) : 739 - 745
  • [6] Microbiologic efficacy of 3-day treatment with azithromycin 1.5% eyedrops for purulent bacterial conjunctivitis
    Denis, F.
    Chaumeil, C.
    Goldschmidt, P.
    Delval, L.
    Pouliquen, P.
    Cochereali, D.
    Chainier, D.
    De Barbeyrac, B.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2008, 18 (06) : 858 - 868
  • [7] Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis
    Robert, P. -Y.
    Bourcier, T.
    Meddeb-Ouertani, A.
    Khairallah, M.
    Zaghloul, K.
    Amraoui, A.
    Bhagat, Y.
    Pop, M.
    Cochereau, I.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2010, 33 (04): : 241 - 248
  • [8] Sulphonamide treatment of bacterial and trachomatous conjunctivitis
    MacCallan, AF
    BRITISH MEDICAL JOURNAL, 1940, 1940 : 482 - 483
  • [9] A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness
    Bremond-Gignac, Dominique
    Messaoud, Riadh
    Lazreg, Sihem
    Speeg-Schatz, Claude
    Renault, Didier
    Chiambaretta, Frederic
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 725 - 732
  • [10] Comparing azithromycin (1.5%) with netilmicin (0.3%) eye drops in pediatric population with bacterial conjunctivitis
    Zengin, Mehmet Ozgur
    Zengin, Neslihan
    Cinar, Esat
    Kuckerdonmez, Cem
    IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI, 2014, 4 (03): : 182 - 185
12345